Hadassah's Melanoma Maven Featured in Hadassah Magazine

May 10, 2017

Hadassah's Melanoma Maven Featured in Hadassah Magazine

Metastatic melanoma is typically fatal, but Hadassah Hospital’s Prof. Michal Lotem, a world-renowned, cutting-edge physician/scientist, is trailblazing new treatments that are being watched around the globe.

Prof. Lotem, head of Hadassah’s Melanoma and Cancer Immunotherapy Center, explains: “We developed a way of genetically engineering the few thousand immune system cells from a metastasized tumor into trillions.” And she is not stopping there. She is working to transform immune cells into even more powerful cancer killers so more patients can be saved from this deadly disease.

Yom HaZikaron, Israel’s Remembrance Day, commemorated on May 1, marked Stewart Greenberg’s five-year anniversary to the day of first meeting Prof. Lotem. Diagnosed with stage four melanoma, he had been told by prestigious medical institutions in the United States that there was nothing more they could do for him, but Prof. Lotem was much more optimistic. She saved his life with a personalized melanoma vaccine! “Michal is our angel,” he says.  “She is very modest, but the truth is that she is at the forefront of worldwide melanoma research.”

Read more about how Prof. Lotem is creating a new way to treat skin cancer in this feature story in Hadassah Magazine, "Using the Immune System to Defeat Melanoma."

No items found.